AXIM Biotechnologies, Inc. (AXIM)

AXIM Biotechnologies Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Assets

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Jun 30, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Cash & Equivalents	0.01	0.16	0.05	0.45	0.46	0.51
Short-Term Investments	-	-	-	-	-	0.21
Cash & Short-Term Investments	0.01	0.16	0.05	0.45	0.46	0.73
Cash Growth	-93.80%	230.90%	-89.56%	-0.92%	-36.97%	-62.91%
Inventory	0.01	-	-	-	-	-
Prepaid Expenses	-	-	0.04	0.16	0.26	0.08
Other Current Assets	-	-	0.01	0.02	-	0.84
Total Current Assets	0.02	0.16	0.1	0.64	0.71	1.64
Property, Plant & Equipment	0.3	0.36	0.11	0.19	0.23	0
Goodwill	-	-	-	-	2.46	-
Other Intangible Assets	3.4	3.59	3.99	4.38	-	-
Long-Term Deferred Charges	-	-	-	-	7.8	-
Other Long-Term Assets	0.01	0.01	0.01	0.01	0.01	0.05
Total Assets	3.73	4.12	4.21	5.32	11.31	1.69

Liabilities

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Jun 30, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Accounts Payable	1.67	2.78	1.32	0.85	0.76	0.75
Accrued Expenses	-	-	-	0.06	0.31	-
Short-Term Debt	-	-	0.03	1.61	0.37	0.04
Current Portion of Leases	0.09	0.09	0.02	0.06	0.05	-
Current Unearned Revenue	0.23	0.3	0.33	-	-	-
Other Current Liabilities	4.57	2.8	1.7	0	0	2.6
Total Current Liabilities	6.57	5.98	3.39	2.58	1.5	3.4
Long-Term Debt	6.6	5.66	5.64	5.06	5.84	5.06
Long-Term Leases	0.09	0.14	-	0.02	0.08	-
Long-Term Deferred Tax Liabilities	-	-	-	-	2.34	-
Total Liabilities	13.26	11.78	9.04	7.66	9.75	8.45

Shareholders' Equity

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Jun 30, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Common Stock	0.03	0.02	0.02	0.01	0.01	0.01
Additional Paid-In Capital	65.18	64.53	59.19	51	43.2	28.62
Retained Earnings	-74.75	-72.18	-64.13	-57.88	-41.85	-35.44
Comprehensive Income & Other	-0	-0.02	0.09	4.53	0.2	0.05
Total Common Equity	-9.53	-7.66	-4.83	-2.34	1.57	-6.76
Shareholders' Equity	-9.53	-7.66	-4.83	-2.34	1.57	-6.76
Total Liabilities & Equity	3.73	4.12	4.21	5.32	11.31	1.69

Additional Metrics

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Jun 30, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Total Debt	6.78	5.89	5.69	6.75	6.34	5.1
Net Cash (Debt)	-6.78	-5.74	-5.64	-6.3	-5.88	-4.37
Net Cash Growth	-	-	-	-	-	-
Net Cash Per Share	-0.03	-0.03	-0.03	-0.05	-0.05	-0.07
Filing Date Shares Outstanding	301.96	278.43	223.65	152	128.86	128.44
Total Common Shares Outstanding	294.46	245.93	192.44	138.1	125.33	64.85
Working Capital	-6.55	-5.82	-3.29	-1.94	-0.78	-1.76
Book Value Per Share	-0.03	-0.03	-0.03	-0.02	0.01	-0.10
Tangible Book Value	-12.93	-11.25	-8.81	-6.72	-0.89	-6.76
Tangible Book Value Per Share	-0.04	-0.05	-0.05	-0.05	-0.01	-0.10
Machinery	0.26	0.26	0.18	0.18	0.13	0.02

Data Source: S&P Global Market Intelligence Last updated: Jun 30, 2024

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jul 29, 2026

Data Sources Report a data error